Medesis Pharma is a clinical-stage Pharmaceutical Biotechnology company developing innovative technology (AONYS®) for the delivery of therapeutic molecules to treat diseases with no current efficacious treatment.
Legal structure :
Montpellier (France) Headquarters
Montreal (Canada) 100% subsidiary. Medesis Pharma Inc. is a subsidiary for collaborations with McGill University and the University of Montreal.
2003
Served areaWorldwide
HeadquartersL'Orée des Mas Avenue du Golf, 34670 Baillargues, Montpellier – France
4,365,344
IPOFeb. 12, 2021
Stock exchange(s)Euronext Paris